Silence Therapeutics PLC Holding(s) in Company (5940J)
June 29 2017 - 6:47AM
UK Regulatory
TIDMSLN
RNS Number : 5940J
Silence Therapeutics PLC
29 June 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Silence Therapeutics Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- --------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-----------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-----------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-----------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
-----------------------------------------------------------------------------------------------------
Other (please Disclosure due to increased aggregation X
specify): of holdings (See 'Box 13 - Additional
Information' below)
---------------------------------------------------------- -----------------------------------------
3. Full name of person(s) Richard Griffiths and controlled
subject to the undertakings
notification obligation:
(iii)
----------------------------------------------------------- --------------------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- --------------------------------------------
5. Date of the transaction 26 June 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- --------------------------------------------
6. Date on which issuer 29 June 2016
notified:
----------------------------------------------------------- --------------------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 22,23,24%
----------------------------------------------------------- --------------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- -------------------------------- --------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- --------------- --------------- ------------- -------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ----------- ----------- ------------- ------------- ----------- ------------ -----------
GB00B9GTXM62 15,269,014 15,269,014 17,458,481 17,458,481 24.94%
--------------- --------------- ------------- ------------- ----------- ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ ------------- ------------------------------ ---------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
---------------- ------------- ------------- --------------- ---------------------------- -----------------------
Nominal Delta
---------------- ------------- ------------- --------------- ---------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
-------------------------------------------------- ------------------------------------------------------------------
17,458,481 24.94%
-------------------------------------------------- ------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------------------------------------------
Blake Holdings Limited 7,428,699
Seren Investment
Management Limited 6,963,708
Sarossa Plc 2,189,467
Oak Trust Limited 182,837
Richard Griffiths
direct holdings 1,617
Richard Griffiths
indirect holdings 692,153
Total 17,458,481
-----------
The above undertakings are all controlled by Richard
Griffiths
Proxy Voting:
------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ---------------------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------------------------------- ---------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------------------------------- ---------------------------------
13. Additional information: Sarossa Plc has now become
a controlled undertaking
of Richard Griffiths for
DTR rule purposes. As such
Sarossa Plc's shareholding
in Silence Therapeutics Plc,
as shown in box 9, is now
aggregated into 'Richard
Griffiths and controlled
undertakings' disclosures.
The movement in shares in
this disclosure is due to
that aggregation and no further
shares in Silence Therapeutics
Plc were acquired by Richard
Griffiths, his controlled
undertakings or Sarossa Plc
as part of this disclosure.
------------------------------------------------------------- ---------------------------------
14. Contact name: James Sutcliffe
------------------------------------------------------------- ---------------------------------
15. Contact telephone number: + 44 1534 719 761
------------------------------------------------------------- ---------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUKSRRBVANUAR
(END) Dow Jones Newswires
June 29, 2017 06:47 ET (10:47 GMT)
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Apr 2024 to May 2024
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From May 2023 to May 2024